LSIPR 50 2016: Roy Waldron


Roy Waldron was selected in the LSIPR 50 2016 publication for his influence on the life sciences industry. Waldron was featured in the legal section, as LSIPR reports.


Name: Roy Waldron

Organisation: Pfizer

Roy Waldron, Pfizer, associate general counsel, chief intellectual property counsel, GSK, Johnson & Johnson, Eli Lilly, Takeda, patent, trademark, legal,